Cargando…
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Despite Polycystic Ovary Syndrome (PCOS) is a very prevalent disorder among women of reproductive age, there is widespread agreement that until now, no pharmacological options are available to tackle the entire spectrum of clinical manifestations encountered in the clinical practice. Obesity and ins...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372121/ https://www.ncbi.nlm.nih.gov/pubmed/37093453 http://dx.doi.org/10.1007/s40618-023-02084-6 |